Skin Neoplasm Clinical Trial
Official title:
A Novel Intervention to Improve Sun Exposure Awareness and Behavior in Children
Verified date | November 2019 |
Source | University of Southern California |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objective of this study is to test a novel classroom-based intervention to motivate youth to limit their sun exposure. The intervention will make the process of learning about sun exposure more person-centered using individual dosimetry readings and feedback that will lead to individual plans for reducing sun exposure.
Status | Completed |
Enrollment | 3750 |
Est. completion date | November 30, 2018 |
Est. primary completion date | January 10, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Child in classrooms from selected schools in the Los Angeles metropolitan area. Exclusion Criteria: - All children will participate in the educational activities, unless they opt out of pre- and post-test questionnaires or are absent from school for any of the education sessions. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Southern California | National Institutes of Health (NIH) |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in sun exposure behavior | Self reported change in sun exposure behavior using 4 questions in a self-completed questionnaire | One week after completion of education activities |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02550678 -
A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT03666325 -
Immunotherapy +/- EGFR Inhibitor In Advanced/Metastatic cSCC: Tackling Primary And Secondary Resistance
|
Phase 2 | |
Terminated |
NCT02602067 -
131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients
|
Phase 1 | |
Recruiting |
NCT05786716 -
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Teenage/Young Adult and Paediatric Patients With Cancers With HER2 Amplification or Activating Mutations
|
Phase 2/Phase 3 | |
Recruiting |
NCT05908435 -
Impact of Sunscreen Dispensers in Parks Visited by Teenagers
|
N/A | |
Completed |
NCT02580916 -
Utility of the Skin Cancer Quality of Life Impact Tool
|
N/A | |
Active, not recruiting |
NCT01167998 -
Early Diagnosis of Malignant Transformation of Pigmentary Skin Lesions
|
||
Completed |
NCT05788939 -
PLANNED VISUAL EDUCATION ABOUT SKIN CANCER
|
N/A | |
Terminated |
NCT03321903 -
EPR Tumor Oximetry With CE India Ink
|
||
Completed |
NCT05068687 -
Peroperative Assessment of Malignancies of the Head and Neck Using High-resolution 18F-FDG-PET/CT
|
N/A |